Best General Drug Manufacturer Stocks to Buy Now (2025)Top general drug manufacturer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.
Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 5th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NVS | NOVARTIS AG | $111.33 | -1.90% | 0.14% | 1.57% | 5.55% | 1.81% | 14.18% | 27.02% | 33.47% | 7.72% | $120.92 | $96.06 | 7.93% | 15.89% | 0.36 | 2,084,708 | -16.66% |
| JNJ | JOHNSON & JOHNSON | $154.46 | -1.18% | -0.30% | 0.79% | 1.71% | -3.54% | 2.17% | -13.54% | 4.16% | 54.26% | $169.99 | $140.68 | 9.14% | 9.80% | 0.27 | 7,218,410 | -24.79% |
| GILD | GILEAD SCIENCES INC | $103.25 | -3.09% | -2.73% | -7.22% | 4.95% | 15.35% | 57.61% | 71.20% | 29.14% | -1.68% | $119.96 | $62.07 | 13.93% | 66.34% | 0.41 | 7,260,323 | -24.60% |
| BMY | BRISTOL MYERS SQUIBB CO | $49.61 | -1.18% | 1.89% | -16.69% | -17.25% | -8.67% | 12.21% | -33.92% | -17.67% | -23.28% | $63.33 | $39.35 | 21.66% | 26.07% | 0.34 | 17,108,653 | 7.25% |
| AZN | ASTRAZENECA PLC | $70.51 | -1.78% | 1.38% | -2.88% | 0.93% | -1.27% | -7.72% | 6.14% | 35.96% | 107.75% | $87.68 | $61.24 | 19.58% | 15.14% | 0.42 | 5,764,039 | 42.06% |
| GSK | GSK PLC | $38.75 | -2.76% | 3.33% | 2.32% | 11.03% | 5.07% | -8.97% | -30.68% | -24.77% | -32.56% | $45.93 | $31.72 | 15.62% | 22.18% | 0.37 | 4,398,608 | -45.24% |
| LLY | ELI LILLY & CO | $794.10 | -11.66% | -7.63% | -1.38% | -2.01% | -3.03% | 2.23% | 174.24% | 416.89% | 986.02% | $972.53 | $677.09 | 18.35% | 17.28% | 0.58 | 12,536,964 | 186.62% |
| ABBV | ABBVIE INC | $193.34 | -0.90% | 7.19% | -6.27% | 1.68% | -5.02% | 19.55% | 30.75% | 133.39% | 200.59% | $218.66 | $153.58 | 11.58% | 25.89% | 0.39 | 5,729,695 | -31.80% |
| BIIB | BIOGEN INC | $120.93 | -0.12% | 1.19% | -8.41% | -15.04% | -30.42% | -44.05% | -41.67% | -58.74% | -68.69% | $238.00 | $110.04 | 49.19% | 9.90% | 0.75 | 2,323,872 | 52.06% |
| GRFS | GRIFOLS SA | $7.02 | 1.01% | -2.23% | 0.86% | 6.04% | -20.59% | 3.39% | -34.94% | -64.60% | -55.93% | $9.96 | $5.79 | 29.52% | 21.24% | 0.71 | 346,926 | -65.80% |
| SNY | SANOFI | $54.10 | -1.55% | 1.05% | -0.44% | 1.41% | 1.56% | 8.14% | 1.96% | 15.47% | 5.48% | $60.12 | $45.80 | 10.01% | 18.12% | 0.35 | 1,512,191 | -10.37% |
| AMGN | AMGEN INC | $283.78 | -2.45% | 1.41% | -7.54% | -1.76% | -11.10% | 2.31% | 22.89% | 22.86% | 76.96% | $346.85 | $253.30 | 18.18% | 12.03% | 0.47 | 2,928,880 | 12.12% |
| PFE | PFIZER INC | $23.93 | -1.97% | 5.05% | -2.49% | -8.66% | -14.81% | -11.96% | -50.50% | -36.42% | -29.78% | $31.54 | $20.92 | 24.13% | 14.42% | 0.42 | 44,280,462 | -17.91% |
| MRK | MERCK & CO INC | $83.26 | -2.28% | 4.28% | -4.43% | -16.56% | -18.28% | -35.36% | -5.01% | 7.20% | 39.09% | $134.63 | $75.93 | 38.16% | 9.65% | 0.32 | 9,964,734 | -27.92% |
| OGN | ORGANON & CO | $9.45 | -26.91% | -22.03% | -33.12% | -36.62% | -47.70% | -49.81% | -70.54% | N/A | N/A | $23.10 | $9.25 | 59.09% | 2.16% | 0.79 | 30,931,107 | 470.43% |
| SCLX | SCILEX HOLDING CO | $5.10 | 7.59% | 15.12% | -38.65% | -65.57% | -85.00% | -82.97% | -98.57% | N/A | N/A | $80.50 | $3.60 | 93.66% | 41.67% | 0.28 | 196,107 | -61.13% |
| AMRN | AMARIN CORP PLC | $10.98 | 2.04% | -1.79% | 24.21% | -0.94% | -6.35% | -34.59% | -79.89% | -92.52% | -70.95% | $20.60 | $7.08 | 46.70% | 55.08% | 1.08 | 80,832 | 5.46% |
| MIRA | MIRA PHARMACEUTICALS INC | $1.14 | -1.72% | 14.69% | 19.37% | -1.72% | -40.00% | 39.19% | N/A | N/A | N/A | $5.01 | $0.51 | 77.25% | 123.53% | 1.77 | 247,833 | -50.12% |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.